Skip to main content
. Author manuscript; available in PMC: 2011 May 30.
Published in final edited form as: J Hypertens. 2008 Jul;26(7):1402–1410. doi: 10.1097/HJH.0b013e3283007dda

Table 1.

Body and heart masses, blood pressure, and histological data

Parameter STC STC + S FAT FAT + S FRU FRU + S SUC SUC + S
Baseline body mass (g) 381 ± 5 378 ± 9 370 ± 10 375 ± 8 360 ± 9 371 ± 18 384 ± 9 381 ± 4
Final body mass (g) 473 ± 8 427 ± 24* 457 ± 18 440 ± 12 420 ± 9 373 ± 23*, 468 ± 13 409 ± 15*
Body fat (%) 20.4 ± 2.1 19.9 ± 2.9 27.0 ± 1.6|| 20.0 ± 1.5* 27.9 ± 2.1|| 17.1 ± 2.3* 28.8 ± 1.2|| 21.4 ± 2.3*
Arterial Systolic Blood Pressure (mmHg)
 Baseline 127 ± 0.6 127 ± 1.2 128 ± 0.5 126 ± 0.9 127 ± 0.9 127 ± 0.7 127 ± 0.4 126 ± 0.6
 6 weeks 126 ± 0.7 222 ± 0.9* 174 ± 1.1 222 ± 0.9* 189 ± 0.9 225 ± 1.1* 205 ± 1.3 225 ± 1.8*
Body fat (%) 20.4 ± 2.1 19.9 ± 2.9 27.0 ± 1.6|| 20.0 ± 1.5* 27.9 ± 2.1|| 17.1 ± 2.3* 28.8 ± 1.2|| 21.4 ± 2.3*
LV mass (g) 1.01 ± 0.02 1.26 ± 0.06* 0.91 ± 0.03 1.24 ± 0.04* 0.82 ± 0.02 1.17 ± 0.06* 1.07 ± 0.02 1.32 ± 0.05*
LV mass/body mass (mg/g) 2.14 ± 0.04 3.00 ± 0.19* 2.00 ± 0.04 2.82 ± 0.06* 1.96 ± 0.04 3.17 ± 0.09*, 2.29 ± 0.09§ 3.23 ± 0.16*,
LV mass/tibial length (mg/cm) 251 ± 7 307 ± 13* 225 ± 9 304 ± 10* 200 ± 5 290 ± 12* 261 ± 7 320 ± 16*
RV mass/tibial length (mg/cm) 66 ± 3 70 ± 5 65 ± 5 76 ± 5 61 ± 2 67 ± 3 67 ± 4 71 ± 7
Myocyte cross-sectional area (μm2) 467 ± 15 546 ± 26 472 ± 37 533 ± 33 457 ± 25 539 ± 31 467 ± 47 551 ± 41
Interstitial fibrosis (%) 10.6 ± 0.7 ND ND ND 10.6 ± 0.7 10.5 ± 0.8 10.4 ± 0.8 9.7 ± 0.6
LV protein fractional synthesis rate (% newly made protein/hr) 1.05 ± 0.09 1.09 ± 0.10 0.82 ± 0.06 1.11 ± 0.08* 1.03 ± 0.08 1.02 ± 0.08 0.96 ± 0.11 1.14 ± 0.08

Values are means ± SEM. FAT, fat; FRU, fructose; LV, left ventricular; RV, right ventricular; S, salt; STC, starch; SUC, sucrose. ND, analysis was not done for these groups.

*

P <0.05 vs. same diet with low salt.

P <0.05 vs. FAT + S.

P <0.05 vs. FAT, FRU.

§

P <0.05 vs. FRU.

||

P <0.05 vs. STC.